Answers are grounded in this paper and cite their sources.
Randomized trial compares HPV testing and cytology for cervical cancer screening, suggesting improvements for health systems.
Does primary HPV testing outperform cytology in real-world, population-based settings—and can health systems manage the consequences? The HIPPO trial, the first prospective randomised study of this kind in Eastern Europe, provides a timely and rigorous answer from within Poland's national screening framework.1
No takes yet. Share an insight, caveat, or question.
Jakimiuk et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: